LinkGevity, an AI-driven drug discovery company focused on revolutionising the treatment of ageing, has been awarded an ...

By preserving organ function at the molecular level, through addressing the core mechanisms of unprogrammed cell death in ATN, LinkGevity could transform treatment pathways for patients at risk of ...

LinkGevity’s anti-necrotic technology, which focuses on acute tubular necrosis (ATN) – a leading cause of kidney dysfunction, ...

It can have potentially disastrous consequences. Doctors explained about 90 per cent of her pancreas had already 'died', causing severe necrotic pancreatitis. Phoebe was sent to the intensive care ...

The Smart Grant will be used in a one-year project involving the company’s Anti-Necrotic™ technology, specifically around acute tubular necrosis (ATN), which is a leading cause of kidney ...

LinkGevity, an AI-driven drug discovery company focused on revolutionising the treatment of ageing, today announces it has been awarded a Smart Grant by the National Innovation Agency of the UK ...